CYFRA reliable marker for response to chemotherapy for NSCLC Researchers discovered that CYFRA and switch in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer in a report of 88 patients viagra salg . Research presented in the April 2012 problem of the International Association for the Study of Lung Cancer’s Journal of Thoracic Oncology implies that this marker may be used to determine whether or not an individual should continue a particular chemotherapy regimen. As part of a study performed by the Malignancy and Leukemia Group B in advanced lung cancer, serum CYFRA levels had been measured at baseline and following the first routine of treatment.
Cardiovascular Innovations and Applications , the new, official journal of the GW-ICC will fill up this void. Unique to this journal would be the continuation of a scientific exchange of tips between leading Chinese clinicians/researchers and clinicians/experts around the globe.' As the state journal of the GW-ICC, CVIA was founded to further the special missions of the GW-ICC: To assist Chinese cardiologists in the developments of cardiovascular learning and disease administration. To accelerate the advancement of cardiology in China, while advocating cardiovascular public health education and affordable use of state-of-the-art cardiovascular technology.